DiaMedica Therapeutics Inc. (DMAC) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts DMAC Hot Sheet
Join SI Premium – FREE
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q3 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).
For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- Yext, Inc. (YEXT) Tops Q2 EPS by 4c
- Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
